Vestipitant is a neurokinin-1 (NK1) receptor antagonist with hypnotic effects and efficacy in treating primary insomnia; it alleviates anxiety and potential depression induced by the agonist GR73632 in gerbils by effectively blocking substance P-mediated extracellular signal-regulated kinase phosphorylation; it is also used for the management of functional dyspnea, anxiety, insomnia, irritable bowel syndrome, gastroesophageal reflux disease, tinnitus, and as an antiemetic agent.